Brief: Alk Says Co Licenses Rights To Neffy

Alk-Abello A/S

09/11/2024 22:32

Nov 9 (Reuters) - ALK-Abello A/S  ALKb.CO :
    * REG-ALK LICENSES RIGHTS TO NEFFY®, THE FIRST APPROVED
ADRENALINE
NASAL SPRAY FOR EMERGENCY TREATMENT OF ALLERGIC REACTIONS
(ANAPHYLAXIS)
    * ALK-ABELLO A/S - ALK TO PAY USD 145 MILLION IN UPFRONT AND
ADDITIONAL FUTURE MILESTONES AND SALES ROYALTIES

Source text:  ID:nGNE86tMlH 
Further company coverage:  ALKb.CO 

 ((Reuters.Briefs@thomsonreuters.com;))